Pathologist at the doorstep of cancer “I know your weaknesses and strength”: an interview with Jean Claude Reubi Vikas Prasad Interview 04 February 2020 Pages: 741 - 743
166Ho microsphere scout dose for more accurate radioembolization treatment planning C ChiesaM Maccauro Editorial 24 December 2019 Pages: 744 - 747
Ethical principles for the application of artificial intelligence (AI) in nuclear medicine Geoff CurrieK Elizabeth HawkEric M. Rohren Editorial 11 January 2020 Pages: 748 - 752
The importance of differentiating between qualitative, semi-quantitative, and quantitative imaging—close only counts in horseshoes Richard M. FlemingMatthew R. FlemingTapan K. Chaudhuri Editorial 17 January 2020 Pages: 753 - 755
Availability of both [177Lu]Lu-DOTA-TATE and [90Y]Y-DOTATATE as PRRT agents for neuroendocrine tumors: can we evolve a rational sequential duo-PRRT protocol for large volume resistant tumors? Sandip BasuRahul V. ParghaneSharmila Banerjee Letter to the Editor 18 October 2019 Pages: 756 - 758
Staging FDG PET-CT changes management in patients with gastric adenocarcinoma who are eligible for radical treatment Karen D. BoschSugama ChickloreCara R. Baker Original Article Open access 03 August 2019 Pages: 759 - 767
18F-FDG PET-MR enterography in predicting histological active disease using the Nancy index in ulcerative colitis: a randomized controlled trial Yan LiBenedikt SchaarschmidtJost Langhorst Original Article 24 October 2019 Pages: 768 - 777
Incidental 18F-FDG uptake in the colon: value of contrast-enhanced CT correlation with colonoscopic findings Julian KirchnerBenedikt M. SchaarschmidtPhilipp Heusch Original Article 07 November 2019 Pages: 778 - 786
Hypoxia-induced modulation of glucose transporter expression impacts 18F-fluorodeoxyglucose PET-CT imaging in hepatocellular carcinoma Hongping XiaJianxiang ChenKam M. Hui Original Article 12 December 2019 Pages: 787 - 797
The superior predictive value of 166Ho-scout compared with 99mTc-macroaggregated albumin prior to 166Ho-microspheres radioembolization in patients with liver metastases Maarten L. J. SmitsMathijs G. DassenMarnix G. E. H. Lam Original Article Open access 09 August 2019 Pages: 798 - 806
Safety and efficacy of radioembolization with glass microspheres in hepatocellular carcinoma patients with elevated lung shunt fraction: analysis of a 103-patient cohort Arighno DasAhsun RiazRiad Salem Original Article 10 September 2019 Pages: 807 - 815
The number of microspheres in Y90 radioembolization directly affects normal tissue radiation exposure Alexander S. PasciakGodwin AbiolaClifford R. Weiss Original Article 18 November 2019 Pages: 816 - 827
Comparative dosimetry between 99mTc-MAA SPECT/CT and 90Y PET/CT in primary and metastatic liver tumors Alexandre JadoulClaire BernardRoland Hustinx Original Article 06 August 2019 Pages: 828 - 837
Quantifying the effects of absorbed dose from radioembolisation on healthy liver function with [99mTc]TcMebrofenin Kathy P WillowsonGeoffrey P SchembriDale L Bailey Original Article 20 January 2020 Pages: 838 - 848
[89Zr]Zr-cetuximab PET/CT as biomarker for cetuximab monotherapy in patients with RAS wild-type advanced colorectal cancer E. J. van HeldenS. G. EliasC. W. Menke-van der Houven van Oordt Original Article Open access 09 November 2019 Pages: 849 - 859
Evaluation of [68Ga]Ga-DATA-TOC for imaging of neuroendocrine tumours: comparison with [68Ga]Ga-DOTA-NOC PET/CT Divya YadavSanjana BallalChandrasekhar Bal Original Article 22 November 2019 Pages: 860 - 869
Biodistribution and first clinical results of 18F-SiFAlin-TATE PET: a novel 18F-labeled somatostatin analog for imaging of neuroendocrine tumors Harun IlhanS. LindnerP. Bartenstein Original Article 06 September 2019 Pages: 870 - 880
Prognostic Significance of Somatostatin Receptor Heterogeneity in Progressive Neuroendocrine Tumor Treated with Lu-177 DOTATOC or Lu-177 DOTATATE Josephine GrafUlrich-Frank PapeVikas Prasad Original Article 14 August 2019 Pages: 881 - 894
PRRT neuroendocrine tumor response monitored using circulating transcript analysis: the NETest Lisa BodeiMark S. KiddIrvin M. Modlin Original Article 14 December 2019 Pages: 895 - 906
Combination treatments to enhance peptide receptor radionuclide therapy of neuroendocrine tumours Samuel AdantGirish M. ShahJean-Mathieu Beauregard Review Article 06 September 2019 Pages: 907 - 921
Tandem peptide receptor radionuclide therapy using 90Y/177Lu-DOTATATE for neuroendocrine tumors efficacy and side-effects - polish multicenter experience Jolanta KunikowskaAnna ZemczakLeszek Królicki Original Article Open access 24 January 2020 Pages: 922 - 933
Broadening horizons with 225Ac-DOTATATE targeted alpha therapy for gastroenteropancreatic neuroendocrine tumour patients stable or refractory to 177Lu-DOTATATE PRRT: first clinical experience on the efficacy and safety Sanjana BallalMadhav Prasad YadavMadhavi Tripathi Original Article 10 November 2019 Pages: 934 - 946
Dose escalation of an Evans blue–modified radiolabeled somatostatin analog 177Lu-DOTA-EB-TATE in the treatment of metastatic neuroendocrine tumors Qingxing LiuYuejuan ChengXiaoyuan Chen Original Article 12 December 2019 Pages: 947 - 957
Preclinical evaluation of [18F]FB-A20FMDV2 as a selective marker for measuring αVβ6 integrin occupancy using positron emission tomography in rodent lung Mayca OnegaChristine A. ParkerJan Passchier Original Article Open access 03 January 2020 Pages: 958 - 966
Clinical quantification of the integrin αvβ6 by [18F]FB-A20FMDV2 positron emission tomography in healthy and fibrotic human lung (PETAL Study) Pauline T. LukeyChristopher CoelloRichard P. Marshall Original Article Open access 09 December 2019 Pages: 967 - 979
The radiosensitizer Onalespib increases complete remission in 177Lu-DOTATATE-treated mice bearing neuroendocrine tumor xenografts Sara LundstenDiana SpiegelbergMarika Nestor Original Article Open access 07 January 2020 Pages: 980 - 990
Noninvasive PET tracking of post-transplant gut microbiota in living mice Yanpu WangChenran ZhangZhaofei Liu Original Article 02 January 2020 Pages: 991 - 1002
TOPKi-NBD: a fluorescent small molecule for tumor imaging Giacomo PirovanoSheryl RobertsThomas Reiner Original Article 16 November 2019 Pages: 1003 - 1010
A case of abdominal wall percutaneous endoscopic gastrostomy site metastatic disease from primary oropharyngeal squamous cell carcinoma S. L. AyesaS. F. Hain Image of the Month 27 January 2020 Pages: 1011 - 1012
Granulomatous hepatitis masquerading as metastases on FDG PET/CT Sayak ChoudhuryArchi AgrawalVenkatesh Rangarajan Image of the Month 22 October 2019 Pages: 1013 - 1014
An aggressive functioning pituitary adenoma treated with peptide receptor radionuclide therapy Majid AssadiReza NematiHojjat Ahmadzadehfar Image of the Month 18 November 2019 Pages: 1015 - 1016
Correction to: A multiparametric analysis based on DCE-MRI to improve the accuracy of parotid tumor discrimination Zhifeng XuShaoyan ZhengMingyong Gao Correction 04 February 2020 Pages: 1017 - 1017